Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.75p
   
  • Change Today:
      0.15p
  • 52 Week High: 4.55
  • 52 Week Low: 2.35
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 229,705
  • Market Cap: £20.00m

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
22.65% above the market average22.65% above the market average22.65% above the market average22.65% above the market average22.65% above the market average
15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average15.38% above the sector average
Price Book Ratio
31.97% below the market average31.97% below the market average31.97% below the market average31.97% below the market average31.97% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
82.39% below the market average82.39% below the market average82.39% below the market average82.39% below the market average82.39% below the market average
60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average
Price Chg 3m
73.85% above the market average73.85% above the market average73.85% above the market average73.85% above the market average73.85% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
69.85% below the market average69.85% below the market average69.85% below the market average69.85% below the market average69.85% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average
Momentum 20
44.36% below the market average44.36% below the market average44.36% below the market average44.36% below the market average44.36% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
72.03% below the market average72.03% below the market average72.03% below the market average72.03% below the market average72.03% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
43.92% below the market average43.92% below the market average43.92% below the market average43.92% below the market average43.92% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
58.62% below the market average58.62% below the market average58.62% below the market average58.62% below the market average58.62% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Operating Profit Loss
58.17% below the market average58.17% below the market average58.17% below the market average58.17% below the market average58.17% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
38.72% below the market average38.72% below the market average38.72% below the market average38.72% below the market average38.72% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Cash
26.31% below the market average26.31% below the market average26.31% below the market average26.31% below the market average26.31% below the market average
2.22% below the sector average2.22% below the sector average2.22% below the sector average2.22% below the sector average2.22% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
76.47% above the market average76.47% above the market average76.47% above the market average76.47% above the market average76.47% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.75p
Change Today 0.15p
% Change 4.17 %
52 Week High 4.55
52 Week Low 2.35
Volume 229,705
Shares Issued 533.35m
Market Cap £20.00m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.7% below the market average12.7% below the market average12.7% below the market average12.7% below the market average12.7% below the market average
21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average
Price Trend
50.82% below the market average50.82% below the market average50.82% below the market average50.82% below the market average50.82% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Income Not Available
Growth
53.98% above the market average53.98% above the market average53.98% above the market average53.98% above the market average53.98% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for 20-Jun-2025

Time Volume / Share Price
16:18 66,967 @ 3.57p
15:21 46 @ 4.00p
11:26 50,000 @ 3.68p
09:34 12,692 @ 3.57p
08:40 100,000 @ 3.60p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page